Variability of aminoglycosides pharmacokinesis in C.F. patients in relation with certain clinical parameters.
Douchain
F
F
Centre de Soins pour la Mucoviscidose, Institut Albert Calmet, Camiers, France.
Lebas
L
L
Houdas
S
S
Chivet
C
C
Bakhache
P
P
Pautard
J C
JC
D000583:Amikacin / Q000493:pharmacokinetics; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics*; D003550:Cystic Fibrosis / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D011014:Pneumonia / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D014031:Tobramycin / Q000493:pharmacokinetics
D000900:Anti-Bacterial Agents; D000583:Amikacin; D014031:Tobramycin